KRAS and colonic neoplasm: IHC staining of tissue microarrays of lung and colorectal cancer patient tissues showed that 63% of lung cancer (n = 69/108) and 62% of colon cancer (n = 31/50) expressed high levels of DX2 and KRAS proteins (Fig. 1g and Supplementary Fig. 2e).